First Light Asset Management
First Light Asset Management, LLC is an employee-owned investment management firm founded in September 2013 and based in Edina, Minnesota, with an additional office in Mill Valley, California. The firm specializes in managing equity portfolios primarily for high net worth individuals, as well as pension plans, charitable organizations, and corporations. First Light focuses on investments in the health care sector, targeting companies across various market capitalizations and industries, including medical devices, biotech, and health care services. The firm employs a fundamental analysis and bottom-up stock picking approach, leveraging both in-house and external research to identify innovative and disruptive solutions within the health care market. With a dedicated team possessing over 90 years of combined experience, First Light seeks to balance risk and return while aiming to deliver superior investment performance for its clients.
Caris Life Sciences
Private Equity Round in 2025
Caris Life Sciences, Inc. is a biotechnology company specializing in molecular profiling and advanced diagnostic technologies aimed at improving cancer patient outcomes. Founded in 1987 and headquartered in Irving, Texas, with additional offices in Phoenix and Basel, the company develops solutions that leverage artificial intelligence and machine learning to analyze the molecular complexity of diseases. Caris offers a range of services, including anatomic pathology, drug development, and molecular analyses of patient samples, which include genomic, transcriptomic, and proteomic profiling. Their Comprehensive Oncology Data Explorer serves as a clinico-genomic data platform. By providing insights into DNA, RNA, and protein profiles, Caris enables healthcare professionals to make more precise and personalized treatment decisions for oncology and other complex diseases. The company operates through distributors across the United States, Europe, Australia, and globally, and has established strategic collaborations to enhance its offerings.
Caris Life Sciences
Private Equity Round in 2020
Caris Life Sciences, Inc. is a biotechnology company specializing in molecular profiling and advanced diagnostic technologies aimed at improving cancer patient outcomes. Founded in 1987 and headquartered in Irving, Texas, with additional offices in Phoenix and Basel, the company develops solutions that leverage artificial intelligence and machine learning to analyze the molecular complexity of diseases. Caris offers a range of services, including anatomic pathology, drug development, and molecular analyses of patient samples, which include genomic, transcriptomic, and proteomic profiling. Their Comprehensive Oncology Data Explorer serves as a clinico-genomic data platform. By providing insights into DNA, RNA, and protein profiles, Caris enables healthcare professionals to make more precise and personalized treatment decisions for oncology and other complex diseases. The company operates through distributors across the United States, Europe, Australia, and globally, and has established strategic collaborations to enhance its offerings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.